Article
Chemosensitivity and radiosensitivity profiles of four new human epithelial ovarian cancer cell lines exhibiting genetic alterations in BRCA2, TGFbeta-RII, KRAS2, TP53 and/or CDNK2A.
Cancer chemotherapy and pharmacology - 1 Dec 2004
Samouëlian V, Maugard C M, Jolicoeur M, Bertrand R, Arcand S L, Tonin P N, Provencher D M, Mes-Masson A-M
Abstract excerpt
To address the cellular basis for the response to ovarian cancer treatment, we characterized the chemosensitivity and radiosensitivity of four human epithelial ovarian cancer cell lines that harbor different genetic alterations. The TOV-21G, TOV-81D, OV-90, and TOV-112D cell lines were derived fr...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.